The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
On April 29, Bharat Biotech announced a cut in the price of ”Covaxin” for states to Rs 400 per dose from the earlier Rs 600 per dose.
This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.
India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.
Source link
